Reduced fear-recognition sensitivity following acute buprenorphine administration in healthy volunteers
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
In rodents, the endogenous opioid system has been implicated in emotion regulation, and in the reduction of fear in particular. In humans, while there is evidence that the opioid antagonist naloxone acutely enhances the acquisition of conditioned fear, there are no corresponding data on the effect of opioid agonists in moderating responses to fear. We investigated whether a single 0.2mg administration of the mu-opioid agonist buprenorphine would decrease fear sensitivity with an emotion-recognition paradigm. Healthy human subjects participated in a randomized placebo-controlled within-subject design, in which they performed a dynamic emotion recognition task 120min after administration of buprenorphine and placebo. In the recognition task, basic emotional expressions were morphed between their full expression and neutral in 2% steps, and presented as dynamic video-clips with final frames of different emotional intensity for each trial, which allows for a fine-grained measurement of emotion sensitivity. Additionally, visual analog scales were used to investigate acute effects of buprenorphine on mood. Compared to placebo, buprenorphine resulted in a significant reduction in the sensitivity for recognizing fearful facial expressions exclusively. Our data demonstrate, for the first time in humans, that acute up-regulation of the opioid system reduces fear recognition sensitivity. Moreover, the absence of an effect of buprenorphine on mood provides evidence of a direct influence of opioids upon the core fear system in the human brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development and validation of a brief screening version of the Childhood Trauma Questionnaire
Bernstein, D. P., Stein, J. A., Newcomb, M. D., Walker, E., Pogge, D., Ahluvalia, T., Stokes, J., Handelsman, L., Medrano, M., Desmond, D., et al. (2003) · Child Abuse & Neglect · doi:10.1016/s0145-2134(02)00541-0 · Cited by 6,419
Statistical Analysis of Correlated Data Using Generalized Estimating Equations: An Orientation
Hanley, J. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf215 · Cited by 2,185
Costafreda, S. G., Brammer, M. J., David, A. S., & Fu, C. H. Y. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.10.012 · Cited by 772 · cited 1×
“Not only is the human amygdala very sensitive to facial expressions and especially to facial fear (Costafreda et al., 2008), but Mu-Opioid Receptors (MORs) are also highly expressed in the intercalated and the basolateral nuclei of this structure (Jacobsen et al.”
BackgroundBos, P. A., Panksepp, J., Bluthé, R.-M., & Honk, J. V. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.01.002 · Cited by 429
Self-citationBhagwagar, Z., Cowen, P. J., Goodwin, G. M., & Harmer, C. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.166 · Cited by 189
Stern, R. A., Arruda, J. E., Hooper, C. R., Wolfner, G. D., & Morey, C. E. (1997) · Aphasiology · doi:10.1080/02687039708248455 · Cited by 186
Altered central μ-opioid receptor binding after psychological trauma
Liberzon, I., Taylor, S. F., Phan, K. L., Britton, J. C., Fig, L. M., Bueller, J. A., Koeppe, R. A., & Zubieta, J.-K. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.021 · Cited by 118
The Role of Amygdalar Mu-Opioid Receptors in Anxiety-Related Responses in Two Rat Models
Wilson, M. A., & Junor, L. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301675 · Cited by 76
Human studies on the μ opiate receptor agonist fentanyl: Neuroendocrine and behavioral responses
Hoehe, M., Duka, T., & Doenicke, A. (1988) · Psychoneuroendocrinology · doi:10.1016/0306-4530(88)90046-7 · Cited by 38
Method development studies for repeatedly measuring anxiolytic drug effects in healthy humans
Klumpers, F., van Gerven, J., Prinssen, E., Niklson Roche, I., Roesch, F., Riedel, W., Kenemans, J., & Baas, J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109103115 · Cited by 27
Cited by
Opioid system and human emotions
Nummenmaa, L., & Tuominen, L. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13812 · Cited by 178
Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors
Falcon, E., Browne, C. A., Leon, R. M., Fleites, V. C., Sweeney, R., Kirby, L. G., & Lucki, I. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.38 · Cited by 118
“In addition, studies in healthy controls have shown that low doses of BPN can reduce the sensitivity to fearful facial expressions (Ipser et al, 2013) and enhanced the *Correspondence: Dr I Lucki, Department of Psychiatry, University of Pennsylvania, 125 South 31st Street, Room 2204, Philadelphia,…”
Ahmadi, J., Jahromi, M. S., & Ehsaei, Z. (2018) · Trials · doi:10.1186/s13063-018-2843-9 · Cited by 48
Metadata
- Authors
- Ipser, J. C., Terburg, D., Syal, S., Phillips, N., Solms, M., Panksepp, J., Malcolm-Smith, S., Thomas, K., Stein, D. J., & van Honk, J.
- Venue
- Psychoneuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 38
- Issue
- 1
- Pages
- 166-170
- ISSN
- 0306-4530 (ISSN-L)
- OpenAlex
- W2151689440
- Cited by
- 55
- References
- 10
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduced fear-recognition sensitivity following acute buprenorphine administration in healthy volunteers. https://app.cochat.ai/papers/10.1016/j.psyneuen.2012.05.002
- The paper
- Ipser, J. C., Terburg, D., Syal, S., Phillips, N., Solms, M., Panksepp, J., Malcolm-Smith, S., Thomas, K., Stein, D. J., & van Honk, J. (2013). Reduced fear-recognition sensitivity following acute buprenorphine administration in healthy volunteers. Psychoneuroendocrinology. https://doi.org/10.1016/j.psyneuen.2012.05.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.